Screener
Beta Bionics BBNX Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Beta Bionics in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesAndOtherLiabilities.
The source filing: Beta Bionics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323777
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $5,351 | $4,998 |
| Accrued expenses and other current liabilities | 17,194 | 22,431 |
| Operating lease liabilities | 1,591 | 1,938 |
| Deferred revenue | 1,881 | 1,557 |
| Total current liabilities | 26,017 | 30,924 |
| Operating lease liabilities, net of current portion | 4,921 | 5,365 |
Item 1. Financial Statements.
FAQ
- What is Beta Bionics's accrued expenses?
- Beta Bionics (BBNX) reported accrued expenses of $17.19M in Q2 2026.
- How has Beta Bionics's accrued expenses changed year-over-year?
- Beta Bionics's accrued expenses increased by 28.3% year-over-year, from $13.41M to $17.19M.
- What is the long-term trend for Beta Bionics's accrued expenses?
- Over 2 years (2023 to 2025), Beta Bionics's accrued expenses has grown at a 66.1% compound annual growth rate (CAGR), from $8.13M to $22.43M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Beta Bionics's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude